Jon E Sprague

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Topics

African American

Prefrontal Cortex

Liquid Chromatography Tandem Mass Spectrometry

Top Venues

The pharmacogenomics journal

Addiction biology

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew L Banks, Jon E Sprague
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder. Addiction biology 29 (2) (2024)
Matthew L Banks, Jon E Sprague
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder. Addiction biology 29 (2) (2024)
Matthew L Banks, Jon E Sprague
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder. Addiction biology 29 (2) (2024)
Robert Goldsmith, Amal Aburahma, Jon E Sprague
Dopamine Concentration Changes Associated with the Retrodialysis of Methylone and 3,4-Methylenedioxypyrovalerone (MDPV) into the Caudate Putamen. Brain sciences 14 (3) (2024)
Robert Goldsmith, Amal Aburahma, Jon E Sprague
Dopamine Concentration Changes Associated with the Retrodialysis of Methylone and 3,4-Methylenedioxypyrovalerone (MDPV) into the Caudate Putamen. Brain sciences 14 (3) (2024)
Jeremy R Canfield, Kristin V Canfield, Jon E Sprague
Para-fluorofentanyl: Coincidence or intentional? Addiction (Abingdon, England) 119 (9) (2024)
Jeremy R Canfield, Kristin V Canfield, Jon E Sprague
Para-fluorofentanyl: Coincidence or intentional? Addiction (Abingdon, England) (2024)
Jon E Sprague, Caroline E Freiermuth, Joshua Lambert, Robert Braun, Jennifer A Frey, Daniel J Bachmann, Jason J Bischof, Lauren Beaumont, Michael S Lyons, Michael V Pantalon, Brittany E Punches, Rachel Ancona, David F Kisor
Opioid use disorder risk alleles in self-reported assigned African American/Afro-Caribbean and European biogeographical genetic ancestry groups and in males and females. The pharmacogenomics journal 24 (4) (2024)
Jon E Sprague, Caroline E Freiermuth, Joshua Lambert, Robert Braun, Jennifer A Frey, Daniel J Bachmann, Jason J Bischof, Lauren Beaumont, Michael S Lyons, Michael V Pantalon, Brittany E Punches, Rachel Ancona, David F Kisor
Opioid use disorder risk alleles in self-reported assigned African American/Afro-Caribbean and European biogeographical genetic ancestry groups and in males and females. The pharmacogenomics journal 24 (4) (2024)
Jon E Sprague, Caroline E Freiermuth, Joshua Lambert, Robert Braun, Jennifer A Frey, Daniel J Bachmann, Jason J Bischof, Lauren Beaumont, Michael S Lyons, Michael V Pantalon, Brittany E Punches, Rachel Ancona, David F Kisor
Opioid use disorder risk alleles in self-reported assigned African American/Afro-Caribbean and European biogeographical genetic ancestry groups and in males and females. The pharmacogenomics journal 24 (4) (2024)
Matthew L Banks, Jon E Sprague
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder. Addiction biology 29 (2) (2024)
Matthew L Banks, Jon E Sprague
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder. Addiction biology 29 (2) (2024)
Jon E Sprague, Caroline E Freiermuth, Joshua Lambert, Robert Braun, Jennifer A Frey, Daniel J Bachmann, Jason J Bischof, Lauren Beaumont, Michael S Lyons, Michael V Pantalon, Brittany E Punches, Rachel Ancona, David F Kisor
Opioid use disorder risk alleles in self-reported assigned African American/Afro-Caribbean and European biogeographical genetic ancestry groups and in males and females. The pharmacogenomics journal 24 (4) (2024)
Jon E Sprague, Caroline E Freiermuth, Joshua Lambert, Robert Braun, Jennifer A Frey, Daniel J Bachmann, Jason J Bischof, Lauren Beaumont, Michael S Lyons, Michael V Pantalon, Brittany E Punches, Rachel Ancona, David F Kisor
Opioid use disorder risk alleles in self-reported assigned African American/Afro-Caribbean and European biogeographical genetic ancestry groups and in males and females. The pharmacogenomics journal 24 (4) (2024)
Caroline E Freiermuth, David F Kisor, Joshua Lambert, Robert Braun, Jennifer A Frey, Daniel J Bachmann, Jason J Bischof, Michael S Lyons, Michael V Pantalon, Brittany E Punches, Rachel Ancona, Jon E Sprague
Genetic Variants Associated with Opioid Use Disorder. Clinical pharmacology and therapeutics (2023)
Caroline E Freiermuth, David F Kisor, Joshua Lambert, Robert Braun, Jennifer A Frey, Daniel J Bachmann, Jason J Bischof, Michael S Lyons, Michael V Pantalon, Brittany E Punches, Rachel Ancona, Jon E Sprague
Genetic variants associated with opioid use disorder. Clinical pharmacology and therapeutics (2023)
Amal Aburahma, Emma L Stewart, Srishti Rana, Ray Larsen, Christopher S Ward, Jon E Sprague
Influence of fecal microbial transplant (FMT) between male and female rats on methamphetamine-induced hyperthermia. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 40 (1) (2023)
Jeremy R Canfield, Jon E Sprague
Influence of carbon side chain length on the in vivo pharmacokinetic and pharmacodynamic characteristics of illicitly manufactured fentanyls. Drug testing and analysis (2023)
Amal Aburahma, Emma L Stewart, Srishti Rana, Ray Larsen, Christopher S Ward, Jon E Sprague
Influence of fecal microbial transplant (FMT) between male and female rats on methamphetamine-induced hyperthermia. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 40 (1) (2023)
Myriam Shaw Ojeda, Aleda M H Chen, Tessa Miracle, Elizabeth Delaney, Caroline E Freiermuth, Jon E Sprague
HealthCare educational differences in pain management, adverse childhood experiences and their relationship to substance use disorder education. Substance abuse treatment, prevention, and policy 17 (1) (2022)
Maggie L McCorkle, David F Kisor, Caroline E Freiermuth, Jon E Sprague
Systematic review of Pharmacogenomics Knowledgebase evidence for pharmacogenomic links to the dopamine reward pathway for heroin dependence. Pharmacogenomics 22 (13) (2021)
Diane M Calinski, David F Kisor, Jon E Sprague
A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics. Psychopharmacology 236 (3) (2018)
Achut P Silwal, Rajeev Yadav, Jon E Sprague, H Peter Lu
Raman Spectroscopic Signature Markers of Dopamine-Human Dopamine Transporter Interaction in Living Cells. ACS chemical neuroscience 8 (7) (2017)